5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final overall survival analysis for the phase II RECORD-3 study of first-line everolimus followed by sunitinib versus first-line sunitinib followed by everolimus in metastatic RCC
    Journal Article

    Knox, J. J.; Barrios, C. H.; Kim, T. M.; Cosgriff, T.; Srimuninnimit, V.; Pittman, K.; Sabbatini, R.; Rha, S. Y.; Flaig, T. W.; Page, R. D.; more...
    Annals of Oncology (2017)

    Fulltext@MSK | Save
  • Alkaline phosphatase velocity predicts overall survival and bone metastasis in patients with castration-resistant prostate cancer
    Journal Article

    Hammerich, K. H.; Donahue, T. F.; Rosner, I. L.; Cullen, J.; Kuo, H. C.; Hurwitz, L.; Chen, Y.; Bernstein, M.; Coleman, J.; Danila, D. C.; more...
    Urologic Oncology: Seminars and Original Investigations (2017)

    Fulltext@MSK | Save
  • Combined whole body and multiparametric prostate magnetic resonance imaging as a 1-step approach to the simultaneous assessment of local recurrence and metastatic disease after radical prostatectomy
    Journal Article

    Robertson, N. L.; Sala, E.; Benz, M.; Landa, J.; Scardino, P.; Scher, H. I.; Hricak, H.; Vargas, H. A.
    Journal of Urology (2017)

    Fulltext@MSK | Save
  • Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: Post hoc analysis of PREVAIL
    Journal Article

    Bryce, A. H.; Alumkal, J. J.; Armstrong, A.; Higano, C. S.; Iversen, P.; Sternberg, C. N.; Rathkopf, D.; Loriot, Y.; de Bono, J.; Tombal, B.; more...
    Prostate Cancer and Prostatic Diseases (2017)

    Fulltext@MSK | Save
  • The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer
    Journal Article

    Patel, S. A.; Chen, M. H.; Loffredo, M.; Renshaw, A.; Kantoff, P. W.; D'Amico, A. V.
    Prostate Cancer and Prostatic Diseases (2017)

    Fulltext@MSK | Save
  • Pembrolizumab for advanced urothelial carcinoma - The authors reply
    Journal Article

    Bellmunt, J.; Bajorin, D. F.
    New England Journal of Medicine (2017)

    Fulltext@MSK | Save
  • Transcriptional mechanisms of resistance to anti-PD-1 therapy
    Journal Article

    Ascierto, M. L.; Makohon-Moore, A.; Lipson, E. J.; Taube, J. M.; McMiller, T. L.; Berger, A. E.; Fan, J.; Kaunitz, G. J.; Cottrell, T. R.; Kohutek, Z. A.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • The role of therapeutic layering in optimizing treatment for patients with castration-resistant prostate cancer (prostate cancer radiographic assessments for detection of advanced recurrence II)
    Journal Article

    Crawford, E. D.; Petrylak, D. P.; Shore, N.; Saad, F.; Slovin, S. F.; Vogelzang, N. J.; Keane, T. E.; Koo, P. J.; Gomella, L. G.; O'Sullivan, J. M.; more...
    Urology (2017)

    Fulltext@MSK | Save
  • Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel
    Journal Article

    Armstrong, A. J.; Saad, F.; Phung, D.; Dmuchowski, C.; Shore, N. D.; Fizazi, K.; Hirmand, M.; Forer, D.; Scher, H. I.; De Bono, J.
    Cancer (2017)

    Fulltext@MSK | Save
  • Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
    Journal Article

    Zarbo, A.; Belum, V. R.; Sibaud, V.; Oudard, S.; Postow, M. A.; Hsieh, J. J.; Motzer, R. J.; Busam, K. J.; Lacouture, M. E.
    British Journal of Dermatology (2017)

    Fulltext@MSK | Save